Literature DB >> 18568157

The human oxygen sensing machinery and its manipulation.

Rasheduzzaman Chowdhury1, Adam Hardy, Christopher J Schofield.   

Abstract

Animals respond to the challenge of limited oxygen availability by a coordinated response that works to increase oxygen supply and minimize tissue damage. The chronic hypoxic response is mediated by the alpha,beta-hypoxia inducible transcription factor (HIF) that enables the expression of a gene array. Because this array includes genes encoding for proteins that regulate processes including red blood cell and blood vessel formation, manipulation of the HIF system has potential for the treatment of ischemic diseases, anaemia and tumours. Hydroxylase enzymes act as oxygen sensors by regulating both the lifetime of HIF-alpha and its transcriptional activity. This tutorial review aims to provide a non-expert introduction to the HIF field by providing a background to current work, summarising molecular knowledge on the HIF system, and outlining opportunities for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18568157     DOI: 10.1039/b701676j

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   54.564


  31 in total

1.  Targeted genes and interacting proteins of hypoxia inducible factor-1.

Authors:  Wei Liu; Shao-Ming Shen; Xu-Yun Zhao; Guo-Qiang Chen
Journal:  Int J Biochem Mol Biol       Date:  2012-05-31

2.  Microfluidic platform generates oxygen landscapes for localized hypoxic activation.

Authors:  Megan L Rexius-Hall; Gerardo Mauleon; Asrar B Malik; Jalees Rehman; David T Eddington
Journal:  Lab Chip       Date:  2014-10-15       Impact factor: 6.799

3.  The hypoxic regulator of sterol synthesis nro1 is a nuclear import adaptor.

Authors:  Tzu-Lan Yeh; Chih-Yung S Lee; L Mario Amzel; Peter J Espenshade; Mario A Bianchet
Journal:  Structure       Date:  2011-04-13       Impact factor: 5.006

4.  Affinity-Based Fluorescence Polarization Assay for High-Throughput Screening of Prolyl Hydroxylase 2 Inhibitors.

Authors:  Yonghua Lei; Tianhan Hu; Xingsen Wu; Yue Wu; Qichao Bao; Lianshan Zhang; Hua Xia; Haopeng Sun; Qidong You; Xiaojin Zhang
Journal:  ACS Med Chem Lett       Date:  2015-11-09       Impact factor: 4.345

Review 5.  Extracellular matrix genes as hypoxia-inducible targets.

Authors:  Johanna Myllyharju; Ernestina Schipani
Journal:  Cell Tissue Res       Date:  2009-08-07       Impact factor: 5.249

6.  Evolutionary Genetics of Hypoxia and Cold Tolerance in Mammals.

Authors:  Kangli Zhu; Deyan Ge; Zhixin Wen; Lin Xia; Qisen Yang
Journal:  J Mol Evol       Date:  2018-10-16       Impact factor: 2.395

7.  Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen.

Authors:  Emily Flashman; Lee M Hoffart; Refaat B Hamed; J Martin Bollinger; Carsten Krebs; Christopher J Schofield
Journal:  FEBS J       Date:  2010-08-31       Impact factor: 5.542

Review 8.  Intestinal hypoxia and hypoxia-induced signalling as therapeutic targets for IBD.

Authors:  Sophie Van Welden; Andrew C Selfridge; Pieter Hindryckx
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-08-30       Impact factor: 46.802

9.  Bioavailable affinity label for collagen prolyl 4-hydroxylase.

Authors:  James D Vasta; Joshua J Higgin; Elizabeth A Kersteen; Ronald T Raines
Journal:  Bioorg Med Chem       Date:  2013-04-30       Impact factor: 3.641

10.  Erythrocytosis-associated HIF-2alpha mutations demonstrate a critical role for residues C-terminal to the hydroxylacceptor proline.

Authors:  Paul W Furlow; Melanie J Percy; Scott Sutherland; Charlene Bierl; Mary Frances McMullin; Stephen R Master; Terence R J Lappin; Frank S Lee
Journal:  J Biol Chem       Date:  2009-02-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.